You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications

  • Authors: William J. Gradishar, MD; Stephen R.D. Johnston, MA, FRCP, PhD
  • CME / ABIM MOC Released: 1/30/2023
  • Valid for credit through: 1/30/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for hematologists, oncologists, surgeons, obstetricians, and gynecologists.

The goal of this activity is for learners to be better able to stay abreast of the ongoing clinical advances in the management of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer and their implications for clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest clinical trial data in HR-positive, HER2-negative early breast cancer
    • Advanced therapies for treating HR-positive, HER2-negative early breast cancer
  • Demonstrate greater confidence in their ability to
    • Interpret the implications of the latest clinical trial data on treating HR-positive, HER2-negative early breast cancer


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • William J. Gradishar, MD

    Chief of Hematology and Oncology
    Betsy Bramsen Professor of Breast Oncology
    Robert H. Lurie Comprehensive Cancer Center
    Professor of Oncology
    Northwestern University Feinberg School of Medicine
    Chicago, Illinois, United States

    Disclosures

    William J. Gradishar, MD, has no relevant financial relationships.

  • Stephen R.D. Johnston, MA, FRCP, PhD

    Professor of Breast Cancer Medicine
    Head of Medical Oncology
    Consultant Medical Oncologist
    Head of The Breast Unit
    The Royal Marsden NHS Foundation Trust &
    The Institute of Cancer Research
    London, United Kingdom

    Disclosures

    Stephen R.D. Johnston, MA, FRCP, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca Pharmaceuticals LP; Lilly; Pfizer Inc.; Puma Biotechnology; Sanofi-Genzyme
    Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP; Lilly; Pfizer Inc.; Sanofi-Genzyme
    Research funding from: AstraZeneca Pharmaceuticals LP; Lilly; Pfizer Inc.

Editor

  • Victoria Phoenix, BS

    Medical Education Director, Medscape, LLC

    Disclosures

    Victoria Phoenix, BS, has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications

Authors: William J. Gradishar, MD; Stephen R.D. Johnston, MA, FRCP, PhDFaculty and Disclosures

CME / ABIM MOC Released: 1/30/2023

Valid for credit through: 1/30/2024

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print